Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFDM Group Regulatory News (FDM)

Share Price Information for FDM Group (FDM)

Share Price is delayed by 15 minutes
Get Live Data
100.20    -5.60 (-5.29%)
Bid:
101.40
Ask:
105.60
Spread: 4.20 (4.142%)
Market Cap: £109.56m
FDM Live PriceLast checked at - London Stock Exchange

Intraday FDM Group Share Chart

Year End Trading Update

1 Feb 2023 07:00

RNS Number : 4950O
FDM Group (Holdings) plc
01 February 2023
 

 

1 February 2023

FDM GROUP (HOLDINGS) PLC ("FDM GROUP", "FDM" or "THE GROUP")

YEAR END TRADING UPDATE

FDM Group, a global professional services provider with a focus on Information Technology, today provides a trading update for the year to 31 December 2022, ahead of its full year results, which will be released on 15 March 2023.

Group Trading in the Period and Closing Balance Sheet

The Group performed well in 2022, with each of its primary regions showing year-on-year growth in Consultants deployed, and a particularly strong performance in North America. The Board expects the Group's financial performance for the year to 31 December 2022 to be in line with its expectations.

Revenue for the year to 31 December 2022 is expected to be £330 million, up 23% in comparison to the prior year (2021: £267 million). On a constant currency basis revenue increased by 20%.

The Group ended the year with 4,905 Consultants placed with clients (2021: 4,033), an increase of 22% on the prior year.

The UK closed with 1,958 Consultants deployed (2021: 1,806), an increase of 8% year-on-year. The Group experienced more challenging market conditions in this region later in the year, as the uncertainty that followed September's mini-budget and subsequent changes in UK Government impacted certain customers' decision-making.

North America delivered good growth in Consultant headcount, with pleasing contributions from both the US and Canada, as the Group's initiatives to help meet growing demand took effect. The region closed 48% higher year-on-year, with 1,618 Consultants deployed (2021: 1,095).

APAC increased headcount by 15% year-on-year, closing with 1,011 Consultants deployed (2021: 880). Australia and Singapore each passed their own milestones of 400 and 300 respectively during the year.

The Group's EMEA operations performed well, increasing headcount by 26% to 318 Consultants deployed (2020: 252), with the Group's business in Poland, which opened in the first half of 2021, delivering an encouraging performance.

The Group delivered 3,179 training completions during the year (2021: 2,410 training completions) the highest number in the Group's history.

The Group's balance sheet remains robust with closing cash balances of £46 million (2021: £53 million). Cash conversion remained good at 108.3% (2021: 124.1%). The Group has no debt.

Outlook

Rod Flavell, Group CEO, commented:

"FDM has delivered good growth during 2022, returning a financial performance in line with the Board's expectations.

As we enter 2023 there remains a high degree of macro-economic and political uncertainty in some of the regions where we operate. However, across the Group we continue to see healthy levels of client engagement and activity.

Our scalable and flexible business model and diversified portfolio of clients, sectors and operating regions mean that we are well positioned to weather these uncertainties in 2023 and to continue to deliver long-term growth for our stakeholders."

This announcement may contain statements which constitute 'forward-looking statements'. Although FDM Group believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to have been correct. Because these statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements.

ENDS

For further information, please contact:

FDM Group

Rod Flavell - Chief Executive Officer

Mike McLaren - Chief Financial Officer

Mark Heather - Group Governance Director & Company Secretary

 

 

Tel: +44 (0)20 3056 8240

 

Financial PR

Nick Oborne

Tel: +44 (0)7850 127526

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDGGDBGUXDGXB
Date   Source Headline
8th Jun 20268:24 amRNSDisclosure of PSP Performance Condition Targets
3rd Jun 202611:01 amRNSAdmission to Trading
2nd Jun 20262:23 pmRNSDirector Shareholding & Block Listing Application
1st Jun 20267:00 amRNSTotal Voting Rights
21st May 20264:39 pmRNSResult of AGM
21st May 20267:00 amRNSAGM Statement
27th Apr 20263:51 pmRNSNotification of Transactions of Directors & PDMRs
21st Apr 20262:18 pmRNSDirector / PCA Shareholding
20th Apr 20267:00 amRNSDirector / PCA Shareholding
10th Apr 20264:34 pmRNS2026 Notice of Annual General Meeting
20th Mar 20265:18 pmRNSHolding(s) in Company
18th Mar 20267:00 amRNSPreliminary Results
2nd Mar 20267:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTotal Voting Rights
28th Jan 20267:00 amRNSTrading Statement
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
1st Dec 20259:17 amRNSTotal Voting Rights
13th Nov 202512:35 pmRNSHolding(s) in Company
11th Nov 20257:00 amRNSTrading Statement
6th Nov 20254:05 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSTotal Voting Rights
17th Oct 20251:03 pmRNSDirector/PDMR Shareholding
4th Sep 20254:31 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSHolding(s) in Company
8th Aug 202510:55 amRNSDirector/PDMR Shareholding
5th Aug 202510:03 amRNSHolding(s) in Company
1st Aug 20258:50 amRNSTotal Voting Rights
31st Jul 20255:27 pmRNSPDMR Shareholding
31st Jul 20253:45 pmRNSHolding(s) in Company
30th Jul 20257:00 amRNSHalf-year Report
15th Jul 20255:07 pmRNSHolding(s) in Company
7th Jul 20259:48 amRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirectorate Change
6th Jun 20257:00 amRNSDirector/PDMR Shareholding
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
23rd May 20255:07 pmRNSDirector/PCA Shareholding
20th May 20255:28 pmRNSResult of AGM
20th May 20257:00 amRNSAnnual General Meeting Statement
9th May 202511:10 amRNSDirector/PDMR Shareholding
8th May 20252:55 pmRNSDirector/PDMR Shareholding
1st May 20251:17 pmRNSDirector/PDMR Shareholding
23rd Apr 20259:51 amRNSDirector Shareholding
9th Apr 20254:32 pmRNSDirector/PDMR Shareholding
8th Apr 20255:42 pmRNSNotice of Annual General Meeting
1st Apr 20257:00 amRNSTotal Voting Rights
20th Mar 20254:31 pmRNSDirector / PCR Shareholding
19th Mar 20257:00 amRNSDirectorate Change
19th Mar 20257:00 amRNSPreliminary Announcement of Results FY2024
14th Mar 20254:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.